JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells

被引:18
作者
Senga, T
Iwamoto, T
Kitamura, T
Miyake, Y
Hamaguchi, M
机构
[1] Nagoya Univ, Sch Med, Radioisotope Res Ctr, Div Med,Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi 4668550, Japan
[3] Nagoya Univ, Sch Med, Dept Mol Pathogenesis, Showa Ku, Nagoya, Aichi 4668550, Japan
[4] Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factors, Minato Ku, Tokyo 1088639, Japan
关键词
D O I
10.1074/jbc.M105749200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Ras-related GTPase (Ral) is converted to the GTP-bound form by Ral guanine nucleotide dissociation stimulator (RalGDS), a putative effector protein of Ras. Recently, it was proven that Ral regulates c-Src activity and subsequent phosphorylation of its substrate, STAT3. Here, we show that STAT3 inversely regulates activation of Ral through induction of expression of RalGDS. To identify new leukemia inhibitory factor-induced genes, we have performed representational difference analysis using M1 mouse myeloid leukemia cells and cloned RalGDS. The expression of RalGDS and subsequent activation of RalA were clearly suppressed by a dominant negative form of STAT3 and a JAK inhibitor, JAB/SOCS1/SSI-1, indicating that RalGDS/RalA signaling requires the activation of the JAK/STAT3 pathway. An experiment using a Ras inhibitor demonstrated that full activation of RalA also requires activation of Ras. These results suggest a novel cross-talk between JAW STAT3 and the Ras/RalGDS/Ral signaling pathways through gp130.
引用
收藏
页码:32678 / 32681
页数:4
相关论文
共 31 条
[1]   CHARACTERIZATION OF A GUANINE-NUCLEOTIDE DISSOCIATION STIMULATOR FOR A RAS-RELATED GTPASE [J].
ALBRIGHT, CF ;
GIDDINGS, BW ;
LIU, J ;
VITO, M ;
WEINBERG, RA .
EMBO JOURNAL, 1993, 12 (01) :339-347
[2]   Transcriptional activation of the p21WAF1,CIP1,SDI1 gene by interleukin-6 type cytokines -: A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells [J].
Bellido, T ;
O'Brien, CA ;
Roberson, PK ;
Manolagas, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :21137-21144
[3]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[4]   Stat3 activation is required for cellular transformation by v-src [J].
Bromberg, JF ;
Horvath, CM ;
Besser, D ;
Lathem, WW ;
Darnell, JE .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) :2553-2558
[5]   THE RAL GENE - A NEW RAS RELATED GENE ISOLATED BY THE USE OF A SYNTHETIC PROBE [J].
CHARDIN, P ;
TAVITIAN, A .
EMBO JOURNAL, 1986, 5 (09) :2203-2208
[6]   Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras [J].
deRooij, J ;
Bos, JL .
ONCOGENE, 1997, 14 (05) :623-625
[7]   Evidence for a Ras/Ral signaling cascade [J].
Feig, LA ;
Urano, T ;
Cantor, S .
TRENDS IN BIOCHEMICAL SCIENCES, 1996, 21 (11) :438-441
[8]   Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis [J].
Fukada, T ;
Hibi, M ;
Yamanaka, Y ;
TakahashiTezuka, M ;
Fujitani, Y ;
Yamaguchi, T ;
Nakajima, K ;
Hirano, T .
IMMUNITY, 1996, 5 (05) :449-460
[9]   STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition [J].
Fukada, T ;
Ohtani, T ;
Yoshida, Y ;
Shirogane, T ;
Nishida, K ;
Nakajima, K ;
Hibi, M ;
Hirano, T .
EMBO JOURNAL, 1998, 17 (22) :6670-6677
[10]   An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity [J].
Goi, T ;
Shipitsin, M ;
Lu, ZM ;
Foster, DA ;
Klinz, SG ;
Feig, LA .
EMBO JOURNAL, 2000, 19 (04) :623-630